enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dupilumab - Wikipedia

   en.wikipedia.org/wiki/Dupilumab

   Dupilumab. Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis. [6][7][8][4] It is also used for the treatment of eosinophilic esophagitis [9] and prurigo nodularis.

3. Anti-asthmatic agents - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agents

   Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...

4. Aspirin-exacerbated respiratory disease - Wikipedia

   en.wikipedia.org/wiki/Aspirin-exacerbated...

   Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).

5. US FDA approves Dupixent to treat younger kids with ... - AOL

   www.aol.com/news/us-fda-approves-dupixent-treat...

   Dupixent, currently used to treat eczema, asthma and other inflammatory conditions, generated global sales of $8.68 billion in 2022.

6. If You're Living With Asthma, Here's Every Single ... - AOL

   www.aol.com/lifestyle/youre-living-asthma-heres...

   Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...

7. EMA backs approving Sanofi's Dupixent for 'smoker's lungs ...

   www.aol.com/news/fda-extends-deadline-requests...

   French drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD) - also called ...